Deal of the Day — limited-time pharmacy picks!
Rituxem 100mg/10ml Injection

Rituxem 100mg/10ml Injection

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Rituximab

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Vial(s) Of 10ml

About The Product

Lymphoma Cancer

Description

Rituxem 100mg/ 10ml Injection is a type of targeted immunotherapy. The medicine is used in the treatment of non-Hodgkin lymphoma, a type of blood cancer that affects the lymphatic system. It also used to treat rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Its active salt composition is Rituximab which belongs to the drug class of monoclonal antibodies. It works by reducing the inflammation by binding to the CD20 protein on B lymphocytes, triggering their destruction. The medication is only taken under doctor prescription to ensure safe and effective treatment.

​

Uses

• Rheumatoid arthritis
• Blood cancer (Chronic lymphocytic leukemia)
• Non-Hodgkin lymphoma (NHL)
• Granulomatosis with polyangiitis
• Microscopic polyangiitis

Side Effects

  • Every medication has several side effects, Rituxem 100mg Injection also causes various symptoms.
  • Some of them are resolve on their own and some need proper medical attention to treat the symptoms: • Anemia • Muscle spasm • Headache • Urinary tract infection • Fever, chills, and shivering • Inflammation of nasal cavities • Cough, sore throat • Loss of hair • Increased or decreased blood pressure • Chest pain • Hypersensitivity reactions • Hepatitis B viral infection • Memory loss, trouble thinking, difficulty in walking​

How To Use

  • Rituxem 10ml Injection should be correctly administered by a healthcare.
  • Do not self-administer as doctor will guide you better about the dosage and duration.
  • It is given through intravenous infusion only by a nurse in hospital as it requires careful monitoring. ​

How It Works

Rituxem 100mg Injection is a monoclonal antibody that attaches to CD20 proteins on B cells and help the immune system to destroy these cells.

This is helpful when B cells are causing disease (cancer and autoimmunity), thereby reducing abnormal or overall B cells activity in conditions such as certain cancers and autoimmune disease.​

Safety Advice

Alcohol
Rituxem 100mg Injection may cause certain side effects while consuming alcohol. Consult the doctor if the symptoms persist.
Pregnancy
Pregnant women should consult the healthcare supervision whether if Rituxem 100mg Injection should be taken or not to avoid complications during the treatment.
Breast Feeding
Rituxem Injection is passed through the breast milk which is harmful for the baby. So concern your doctor first.
Driving
Driving should avoid while taking Rituxem 100mg Injection as it may cause dizziness and Weakness. Also avoid using machinery while using the medication.
Kidney
Rituxem Injection may interfere with the kidney function. If the person is a kidney patient, should take a proper prescription to the doctor.
Liver
Rituxem Injection may harmful for liver patient as it can be disrupt the liver function and harm the liver In many ways. It is necessary to consult a healthcare professional before using the injection.

FAQs

Rituxem Injection can be taken with other medication but the doctor prescription as doctor will decide the dosage and duration with other medication based on the patient medical history and response to the treatment.

References

  • Onrust, S. V., Lamb, H. M., & Barman Balfour, J. A. (1999). Rituximab. Drugs, 58(1), 79-88. https://pubmed.ncbi.nlm.nih.gov/10439931/
  • Weiner, G. J. (2010, April). Rituximab: mechanism of action. In Seminars in hematology (Vol. 47, No. 2, pp. 115-123). WB Saunders. https://pubmed.ncbi.nlm.nih.gov/20350658/
  • Cerny, T., Borisch, B., Introna, M., Johnson, P., & Rose, A. L. (2002). Mechanism of action of rituximab. Anti-cancer drugs, 13, S3-S10. https://pubmed.ncbi.nlm.nih.gov/12710585/
  • Johnson, P. W. M., & Glennie, M. J. (2001). Rituximab: mechanisms and applications. British journal of cancer, 85(11), 1619-1623. https://pubmed.ncbi.nlm.nih.gov/11742477/
  • Rezvani, A. R., & Maloney, D. G. (2011). Rituximab resistance. Best practice & research Clinical haematology, 24(2), 203-216. https://pubmed.ncbi.nlm.nih.gov/21658619/​

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026